PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...
Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025
> Meeting in English, 7:00 pm (CET): https://www.medincell.com/live-en/ Shareholders are invited to send their questions to communication@medincell.com, or through ...
Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025
Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results